Concepedia

Valeria Merz

VM

Statistics

Publications

19

Citations

944

H-Index

15

Active since

2015

Affiliations

University of Verona(Current)

Azienda Ospedaliera Universitaria Integrata Verona

Ospedale Santa Chiara

Candiolo Cancer Institute

Istituto Oncologico Veneto

Valeria Merz is an author at University of Verona specializing in oncology, medicine, and pharmacology.

ORCID

Publications per year

2015–2024

19

Publications

19

Safety and activity of the TGFβ receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer

Davide Melisi, Do‐Youn Oh, Antoine Hollebecque et al. · Journal for ImmunoTherapy of Cancer · 2021 · 196 citations · Full text

, , +17

Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma

Laura Maggino, Giuseppe Malleo, Giovanni Marchegiani et al. · JAMA Surgery · 2019 · 141 citations · Full text

, , +12

An FGFR3 Autocrine Loop Sustains Acquired Resistance to Trastuzumab in Gastric Cancer Patients

Geny Piro, Carmine Carbone, Ivana Cataldo et al. · Clinical Cancer Research · 2016 · 84 citations

, , +17

Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer

Joris van de Haar, Xuhui Ma, Salo Ooft et al. · Nature Medicine · 2023 · 84 citations · Full text

, , +17

Modulating TAK1 Expression Inhibits YAP and TAZ Oncogenic Functions in Pancreatic Cancer

Raffaela Santoro, Marco Zanotto, Francesca Simionato et al. · Molecular Cancer Therapeutics · 2019 · 62 citations · Full text

, , +17

1–5 of 19